The quality of life after a total gastrectomy with extended lymphadenectomy and omega type oesophagojejunostomy for gastric adenocarcinoma without distant metastases

BMC Surgery

Raimundas Lunevicius¹  Giedre Smailyte²  Narimantas Evaldas Samalavicius²  Gintare Jakstaite² 

[1] Liver, Renal & Surgery Department, King’s College Hospital NHS Foundation Trust, King’s Health Partners Academic Health Sciences Centre, Denmark Hill, London, SE5 9RS, UK;Clinic of Oncosurgery of Oncology Institute, Clinic of Internal Diseases, Family Medicine and Oncology of Medical Faculty, Vilnius University, 1 Santariskiu Street, Vilnius, LT-08660, Lithuania

关键词: Quality of life;    Omega esophagojejunostomy;    Extended lymphadenectomy;    Total gastrectomy;    Gastric cancer;   

Others  :  1123380
DOI  :  10.1186/1471-2482-12-11

 received in 2012-02-12, accepted in 2012-06-27,  发布年份 2012

【 摘 要 】

Background

To evaluate the quality of life (QOL) in relation to age, sex, clinical stage, postoperative complication, and adjuvant chemotherapy in patients who underwent curative total gastrectomy with D2 lymphadenectomy and Omega type esophagojejunostomy for gastric adenocarcinoma.

Methods

69 patients were included. Lithuanian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cancer 30 was sent to all of them from six months to two years after gastric surgery for self-completion. 34 questionnaires were filled and were used as material for further analysis. Influence of age (≥ 65 vs < 65), sex, clinical stage (I–II vs III), surgical complication, and adjuvant chemotherapy was assessed on QOL in this retrospective cross-sectional case series study.

Results

The global health status was better in the group of patients aged over 65 (63.0 points vs 46.4, P = 0.0509). The functional scales were higher in the same group of patients. Significant difference was only observed on the social scale in favour of elders (P = 0.0039). Sex, clinical stage, surgical complications, and postoperative chemotherapy had no significant influence on any aspect of QOL.

Conclusion

The global QOL and the social functioning was better in patients aged 65 years and over, compared to patients under the age of 65 in the period of 6 to 18 months after a total gastrectomy with D2 lymphadenectomy and Omega esophagojejunostomy.

【 授权许可】

   
2012 Jakstaite et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Schipper H, Clinch J, Powell V: Definitions and conceptual issues. In Quality of Life Assessments in Clinical Trials. Edited by Spilker B. Raven, New York; 1990:11-24.
• [2]Neugebauer E, Troidl H, Wood Dauphine S, Bullinger M: Meran conference on quality-of-life assessment in surgery. Theor Surg 1991, 6:121-165. 195–220
• [3]Rutten LJ, Arora NK, Bakos AD, Aziz N, Rowland J: Information needs and sources of information among cancer patients: a sytematic review of research. Patient Educ Couns 2005, 57:250-261.
• [4]Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J: Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006, 24:3178-3186.
• [5]Kaptein AA, Morita S, Sakamoto J: Quality of life in gastric cancer. World J Gastroenterol 2005, 11:3189-3196.
• [6]Sobin LH: TNM classification of malignant tumors. 7th edition. Edited by Gospodarowicz MK, Wittekind Ch. Wiley-Blackwell, Oxford; 2009.
• [7]Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. Gastric Cancer 1998, 1:10-24. 2nd English Edn
• [8]Hoksch B, Ablassmaier B, Zieren J, Mueller J: Quality of life after gastrectomy: Longmire’s reconstruction alone compared with additional pouch reconstruction. World J Surg 2002, 26:335-341.
• [9]Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Nat Cancer Inst 2000, 92:205-216.
• [10]Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993, 85:365-376.
• [11]Aaronson NK, Cull A, Kaasa S, Sprangers MAG: The EORTC modular approach to quality-of-life assessment in oncology. Int J Ment Health 1994, 23:75.
• [12]Fayers P, Aaronson N, Bjordal K, Groenvold M, Aaronson NK: EORTC QLQ-C30 Scoring Manual. Brussels, EORTC Study Group on Quality of Life; 1995:31-36.
• [13]Thybusch-Bernhardt A, Schmidt C, Kuechler T, Schmid A, Henne-Bruns D, Kremer B: Quality of life following radical surgical treatment of gastric carcinoma. World J Surg 1999, 23:503-508.
• [14]de Liaño AD, Martínez FO, Ciga MA, Aizcorbe M, Cobo F, Trujillo R: Impact of surgical procedure for gastric cancer on quality of life. Br J Surg 2003, 90:91-94.
• [15]Langenhoff BS, Krabbe PFM, Wobbes T, Ruers TJM: Quality of life as an outcome measure in surgical oncology. Br J Surg 2001, 88:643-652.
• [16]Rutegard M, Hughes R, Lagergren P, Blazeby JM: Determinants of global quality of life before and after major cancer surgery: an exploratory study. Qual Life Res 2009, 18:1131-1136.
• [17]Matsushita T, Matsushima E, Maruyama M: Assessment of peri-operative quality of life in patients undergoing surgery for gastrointestinal cancer. Support Care Cancer 2004, 12:319-325.
• [18]Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS: Quality of Life in Disease-Free Gastric Adenocarcinoma Survivors: Impacts of Clinical Stages and Reconstructive Surgical Procedures. Dig Surg 2007, 24:59-65.
• [19]Koster R, Gerbbenslerben B, Stutzer H, Salzberger B, Ahrens P, Rohde H: Quality of life in gastric cancer. Karnofsky’s scale and Spitzer’s index in comparison at the time of surgery in a cohort of 1081 patients. Scand J Gastroenterol 1987, 22:102-106.
• [20]Wu CW, Hsieh MC, Lo SS, Lui WY, P’eng FK: Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg 1997, 21:777-782.
• [21]Wu C-W, J-M Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Peng JW: Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008, 98:54-59.